STAR COMBO PHARMA LIMITED — Share Issue/Capital Change 2021

Nov 29, 2021

==> picture [117 x 53] intentionally omitted <==

STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 sales@starcombo.com.au

ASX Announcement

30 November 2021

Share Cancellation

Resolution 4 at the AGM held on 23 November 2021 provided as follows:

To consider, and if thought fit, to pass the following resolution as a special resolution :

“That 125,741 shares in the Company issued to DW & RL Pty Ltd and 83,827 shares in the Company issued to Liang Zuo pursuant to the ATY and KOM Share Sale and Purchase Agreement dated 5 February 2019 be cancelled and the capital of the Company be reduced accordingly.”

Description	Pre Meeting	Movement	Post Meeting
	number on issue		number on issue
Ordinary Shares	96,317,391		96,317,391
Escrowed Shares - 2022	38,265,510		38,265,510
Escrowed Shares - 2021	209,568	(209,568)	0
Total Voting and Listed Shares	134,792,469	(209,568)	134,582,901
Share Options	1,110,000		1,110,000

The ASIC Form 484 is attached.

Authorised for Release by Patrick Raper – Company Secretary

For further details contact: Patrick Raper Company Secretary Star Combo Pharma Limited

E: PatrickRaper@StarCombo.com.au

About Star Combo Pharma

Star Combo Pharm (ASX: S66) is a leading distributor and manufacturer of branded premium health and natural beauty products. Based in Sydney, our products are distributed to both local Australians and to overseas markets. Star Combo has offices and distribution agreements in China and currently supplies Australian pharmacy lines as well as distribution to over 450 Terry White and Symbion Chemists and wholesale customers in Australia and China. Directed by pharmacists and experts in health supplement manufacturing, Star Combo's vision is to curate health products made from natural ingredients with scientific R&D and manufacturing practices. Since its establishment in 2004, Star Combo has demonstrated strong product and business development and continues its vision to expand our current operations to serve our loyal business partners, customers and employees.

Page 1

Australian Securities & Investments Commission

Electronic Lodgement

Document No. 7EBC54261

Lodgement date/time: 24-11-2020 19:39:24 Reference Id: 147327930

Form 484 Corporations Act 2001

Change to company details

Company details

Company name STAR COMBO PHARMA LTD Australian Company Number (ACN) 615 728 375

Lodgement details

Who should ASIC contact if there is a query about this form?

Name

PATRICK JAMES RAPER

ASIC registered agent number (if applicable) 22201

Signature

This form must be signed by a current officeholder of the company.

I certify that the information in this form is true and complete Name

PATRICK JAMES RAPER

Capacity Secretary

Signature

Date signed 24-11-2020

ASIC Form 484 Ref 14732793024/11/2020

Page 1 of 2

Form 484 - Change to company details STAR COMBO PHARMA LTDACN615 728 375

C1 Cancellation of shares

Reason for cancellation Shares cancellation details Reason for cancellation Other reason for cancellation Section reference 256 C (2) a Description Special Resolution passed at AGM on 24 Nov 2020 The cancelled shares are listed below: Share class code Number of shares Amount paid (cash cancelled or otherwise) ORD 824132 420306 Earliest Date of 24-11-2020 cancellation

C3 Change to share structure

The updated details for this changed share class are shown in the table below.

Share classcode	Full title if not standard	Total number ofshares	Total amount paid onthese shares	Total amount unpaidon these shares
ORD	ORDINARY SHARES	134792469	85042062.74	0.00
Earliest date ofchange24-11-2020

ASIC Form 484 Ref 14732793024/11/2020

Page 2 of 2